Abbott India Ltd (ABOT)

Currency in INR
26,600.00
+490.00(+1.88%)
Closed·
Advertisement
ABBOTINDIA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
26,130.0026,795.00
52 wk Range
24,650.0030,655.00
Key Statistics
Bid/Ask
26,555.00 / 26,585.00
Prev. Close
26,600
Open
26,215
Day's Range
26,130-26,795
52 wk Range
24,650-30,655
Volume
9.39K
Average Volume (3m)
8.53K
1-Year Change
-10.044%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABBOTINDIA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Abbott India Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Hold30,800.00+15.79%29,900.00Maintain06/11/2026
ICICI Securities
Buy33,500.00+25.94%32,550.00Maintain06/11/2026
Bernstein SocGen Group
Hold24,851.00-6.58%-New Coverage04/11/2026
ICICI Securities
Buy32,550.00+22.37%32,000.00Maintain13/08/2026
JPMorgan
Hold27,500.00+3.38%34,000.00Downgrade15/04/2026

Earnings

Latest Release
05/11/2026
EPS / Forecast
213.40 / 213.80
Revenue / Forecast
19.51B / 18.51B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 777.84
Dividend Yield
2.51%
Industry Median 0.64%
Annualised payout
656.00
Paid annually
5-Years Growth
+34.34%
Growth Streak

Compare ABBOTINDIA to Peers and Sector

Metrics to compare
ABBOTINDIA
Peers
Sector
Relationship
P/E Ratio
34.2x32.9x−0.2x
PEG Ratio
3.590.970.00
Price/Book
13.2x6.0x2.6x
Price / LTM Sales
7.9x4.7x2.8x
Upside (Analyst Target)
20.0%14.9%63.4%
Fair Value Upside
Unlock1.6%9.5%Unlock

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Employees
3679
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.61M7.56%41.96B
Other Institutional Investors
16.19M76.19%422.72B
Public Companies & Retail Investors
3.45M16.25%90.13B
Total
21.25M100.00%554.82B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Abbott Laboratories74.99%15,934,048416,037,993
SBI Funds Management Limited2.43%515,80713,467,721

People Also Watch

1,899.70
IPCA
-2.00%
2,008.80
DLPA
-0.98%
558.05
KPIE
+2.21%
3,909.10
BSEL
+0.08%
1,196.00
COCH
-0.50%

FAQ

What Is the Abbott India (NSE: ABBOTINDIA) Share Price Today?

The Abbott India stock price today is 26,600.00 INR.

What Stock Exchange Does Abbott India (ABBOTINDIA) Trade On?

Abbott India is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for Abbott India?

The stock symbol (also called a 'ticker') for Abbott India is "ABBOTINDIA."

Does Abbott India Pay Dividends? What’s The Current ABBOTINDIA Dividend Yield?

Yes, ABBOTINDIA Pays Dividends to its Shareholders. The current Abbott India dividend yield is 2.5%%.

What Is the Current Abbott India Market Capitalisation?

As of today, Abbott India (NSE: ABBOTINDIA) market cap is 565.31B INR.

What Is Abbott India's (ABBOTINDIA) Earnings Per Share (TTM)?

The Abbott India EPS is currently 777.84 (Trailing Twelve Months).

When Is the Next Abbott India Earnings Date?

Abbott India's next earnings report will be released on 10/02/2027.

Is ABBOTINDIA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Abbott India moving averages and other technical indicators, the daily buy/sell signal for ABBOTINDIA stock is Strong Buy.

How Many Times Has Abbott India Stock Split?

Abbott India has split 0 times. (See the ABBOTINDIA stock split history page for full effective split date and price information.)

How Many Employees Does Abbott India Have?

Abbott India has 3679 employees, based on their latest Companies House report.

What is the current trading status of Abbott India (NSE: ABBOTINDIA)?

As of 13/11/2026, Abbott India (ABBOTINDIA) is trading at a share price of 26,600.00 INR, with a previous close of 26,600.00 INR. The stock has fluctuated within a day range of 26,130.00 INR to 26,795.00 INR, while its 52-week range spans from 24,650.00 INR to 30,655.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.